Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Profit After TaxShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
EBIATReceivables - NetReceivables - OtherReceivables RefundsShares OutstandingShares Outstanding
Ratios

Nanobiotix (NBTX) Shares Outstanding (2020 - 2025)

Nanobiotix has reported Shares Outstanding over the past 6 years, most recently at $56.4 million for Q4 2025.

  • For Q4 2025, Shares Outstanding rose 11.19% year-over-year to $56.4 million; the TTM value through Dec 2025 reached $56.4 million, up 11.19%, while the annual FY2025 figure was $56.4 million, 11.19% up from the prior year.
  • Shares Outstanding for Q4 2025 was $56.4 million at Nanobiotix, up from $50.7 million in the prior quarter.
  • Over five years, Shares Outstanding peaked at $56.4 million in Q4 2025 and troughed at $35.6 million in Q4 2022.
  • A 5-year average of $46.6 million and a median of $50.7 million in 2024 define the central range for Shares Outstanding.
  • Biggest five-year swings in Shares Outstanding: decreased 10.69% in 2022 and later soared 42.52% in 2023.
  • Year by year, Shares Outstanding stood at $39.8 million in 2021, then fell by 10.69% to $35.6 million in 2022, then soared by 42.52% to $50.7 million in 2023, then decreased by 0.06% to $50.7 million in 2024, then rose by 11.19% to $56.4 million in 2025.
  • Business Quant data shows Shares Outstanding for NBTX at $56.4 million in Q4 2025, $50.7 million in Q4 2024, and $50.7 million in Q4 2023.